Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.99.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.99.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.99.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.99.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KT.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KT.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KT.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KT.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JC.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-16984.7China
JC.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JC.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.334ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.334ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.334ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.334NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.359ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.359ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.359ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.359NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.302ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.302ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.302ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.302NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.222ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.222ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.222ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.222NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.434ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.434ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.434ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.434NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.467ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.467ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.467ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.467NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.110.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.110.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.110.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.110.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.23 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.23 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.23 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.23 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.9 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.9 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.9 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.9 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.74 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.74 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used